|
[1]
|
Wang, C. and Zhu, X. (2013) The Fourth Edition of WHO Classification of Tumours of Bone: An Introduction. Chinese Journal of Pathology, 42, 652-654.
|
|
[2]
|
Siegel, D.A., Richardson, L.C., Henley, S.J., Wilson, R.J., Dowling, N.F., Weir, H.K., et al. (2020) Pediatric Cancer Mortality and Survival in the United States, 2001‐2016. Cancer, 126, 4379-4389. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Strauss, S.J., Frezza, A.M., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., et al. (2021) Bone Sarcomas: ESMO-EURACAN-GENTURIS-ERN Paedcan Clinical Practice Guideline for Diagnosis, Treatment and Follow-Up. Annals of Oncology, 32, 1520-1536. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Wan-Ibrahim, W.I., Singh, V.A., Hashim, O.H. and Abdul-Rahman, P.S. (2015) Biomarkers for Bone Tumors: Discovery from Genomics and Proteomics Studies and Their Challenges. Molecular Medicine, 21, 861-872. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
de Pinieux, G., Karanian, M., Le Loarer, F., Le Guellec, S., Chabaud, S., Terrier, P., et al. (2021) Nationwide Incidence of Sarcomas and Connective Tissue Tumors of Intermediate Malignancy over Four Years Using an Expert Pathology Review Network. PLOS ONE, 16, e0246958. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Mulder, E.A. (1993) Radiologic Atlas of Bone Tumors. Elsevier.
|
|
[7]
|
Wu, A., Li, G., Zheng, J., Chen, C., Chen, D., Qiao, Z., et al. (2019) Chondrosarcoma in a Paediatric Population: A Study of 247 Cases. Journal of Children’s Orthopaedics, 13, 89-99. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Gatta, G., Capocaccia, R., Botta, L., Mallone, S., De Angelis, R., Ardanaz, E., et al. (2017) Burden and Centralised Treatment in Europe of Rare Tumours: Results of RARECAREnet—A Population-Based Study. The Lancet Oncology, 18, 1022-1039. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Amadeo, B., Penel, N., Coindre, J., Ray-Coquard, I., Ligier, K., Delafosse, P., et al. (2020) Incidence and Time Trends of Sarcoma (2000-2013): Results from the French Network of Cancer Registries (FRANCIM). BMC Cancer, 20, Article No. 190. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Ferguson, J.L. and Turner, S.P. (2018) Bone Cancer: Diagnosis and Treatment Principles. American Family Physician, 98, 205-213.
|
|
[11]
|
van den Berg, H., Kroon, H.M., Slaar, A. and Hogendoorn, P. (2008) Incidence of Biopsy-Proven Bone Tumors in Children: A Report Based on the Dutch Pathology Registration “PALGA”. Journal of Pediatric Orthopaedics, 28, 29-35. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Enneking, W.F. (1990) Clinical Musculoskeletal Pathology. 3rd Rev. Edition, University of Florida Press/J. Hillis Miller Health Science Center.
|
|
[13]
|
Gonfiotti, A., Santini, P.F., Campanacci, D., Innocenti, M., Ferrarello, S., Caldarella, A., et al. (2010) Malignant Primary Chest-Wall Tumours: Techniques of Reconstruction and Survival. European Journal of Cardio-Thoracic Surgery, 38, 39-45. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Murphey, M.D. and Kransdorf, M.J. (2021) Staging and Classification of Primary Musculoskeletal Bone and Soft-Tissue Tumors According to the 2020 WHO Update, from the AJR Special Series on Cancer Staging. American Journal of Roentgenology, 217, 1038-1052. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Bovée, J.V., Cleton-Jansen, A., Taminiau, A.H. and Hogendoorn, P.C. (2005) Emerging Pathways in the Development of Chondrosarcoma of Bone and Implications for Targeted Treatment. The Lancet Oncology, 6, 599-607. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Bawa, H.S., Moore, D.D., Pelayo, J.C., Cipriani, N., Mak, G. and Haydon, R.C. (2017) Pediatric Chondrosarcoma of the Sternum Resected with Thorascopic Assistance. The Open Orthopaedics Journal, 11, 479-485. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Marulli, G., Duranti, L., Cardillo, G., Luzzi, L., Carbone, L., Gotti, G., et al. (2014) Primary Chest Wall Chondrosarcomas: Results of Surgical Resection and Analysis of Prognostic Factors. European Journal of Cardio-Thoracic Surgery, 45, e194-e201. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Zibis, A.H., Shrader, W.M. and Segal, L.S. (2010) Case Report: Mesenchymal Chondrosarcoma of the Lumbar Spine in a Child. Clinical Orthopaedics & Related Research, 468, 2288-2294. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Czarnecka, A.M., Synoradzki, K., Firlej, W., Bartnik, E., Sobczuk, P., Fiedorowicz, M., et al. (2020) Molecular Biology of Osteosarcoma. Cancers, 12, Article No. 2130. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Ottaviani, G. and Jaffe, N. (2009) The Epidemiology of Osteosarcoma. In: Jaffe, N., Bruland, O.S. and Bielack, S., Eds., Cancer Treatment and Research, Springer, 3-13. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Huang, Z., Chen, K., Kang, X., Zhang, Q., Hao, L., Li, Y., et al. (2015) Analysis of the Coincidence Rate between Imaging and Pathological Findings of Pulmonary Metastasis in 45 Cases with Invasive Bone and Soft Tissue Sarcoma. Thoracic Cancer, 6, 180-185. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Goorin, A.M., Delorey, M.J., Lack, E.E., Gelber, R.D., Price, K., Cassady, J.R., et al. (1984) Prognostic Significance of Complete Surgical Resection of Pulmonary Metastases in Patients with Osteogenic Sarcoma: Analysis of 32 Patients. Journal of Clinical Oncology, 2, 425-431. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Gill, J., Ahluwalia, M.K., Geller, D. and Gorlick, R. (2013) New Targets and Approaches in Osteosarcoma. Pharmacology & Therapeutics, 137, 89-99. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Riedel, R.F., Larrier, N., Dodd, L., Kirsch, D., Martinez, S. and Brigman, B.E. (2009) The Clinical Management of Chondrosarcoma. Current Treatment Options in Oncology, 10, 94-106. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Dantonello, T.M., Int‐Veen, C., Leuschner, I., Schuck, A., Furtwaengler, R., Claviez, A., et al. (2008) Mesenchymal Chondrosarcoma of Soft Tissues and Bone in Children, Adolescents, and Young Adults: Experiences of the CWS and COSS Study Groups. Cancer, 112, 2424-2431. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Brown, H.K., Tellez-Gabriel, M. and Heymann, D. (2017) Cancer Stem Cells in Osteosarcoma. Cancer Letters, 386, 189-195. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Yan, G., Lv, Y. and Guo, Q. (2016) Advances in Osteosarcoma Stem Cell Research and Opportunities for Novel Therapeutic Targets. Cancer Letters, 370, 268-274. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Gibbs, C.P., Kukekov, V.G., Reith, J.D., Tchigrinova, O., Suslov, O.N., Scott, E.W., et al. (2005) Stem-Like Cells in Bone Sarcomas: Implications for Tumorigenesis. Neoplasia, 7, 967-976. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Gibbs, C.P., Levings, P.P. and Ghivizzani, S.C. (2011) Evidence for the Osteosarcoma Stem Cell. Current Orthopaedic Practice, 22, 322-326. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Martins-Neves, S.R., Lopes, Á.O., do Carmo, A., Paiva, A.A., Simões, P.C., Abrunhosa, A.J., et al. (2012) Therapeutic Implications of an Enriched Cancer Stem-Like Cell Population in a Human Osteosarcoma Cell Line. BMC Cancer, 12, Article No. 139. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Wilson, H., Huelsmeyer, M., Chun, R., Young, K.M., Friedrichs, K. and Argyle, D.J. (2008) Isolation and Characterisation of Cancer Stem Cells from Canine Osteosarcoma. The Veterinary Journal, 175, 69-75. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Fujii, H., Honoki, K., Tsujiuchi, T., et al. (2009) Sphere-Forming Stem-Like Cell Populations with Drug Resistance in Human Sarcoma Cell Lines. International Journal of Oncology, 34, 1381-1386. [Google Scholar] [CrossRef]
|
|
[33]
|
Tirino, V., Desiderio, V., d’Aquino, R., De Francesco, F., Pirozzi, G., Galderisi, U., et al. (2008) Detection and Characterization of CD133+ Cancer Stem Cells in Human Solid Tumours. PLOS ONE, 3, e3469. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Tirino, V., Desiderio, V., Paino, F., De Rosa, A., Papaccio, F., Fazioli, F., et al. (2011) Human Primary Bone Sarcomas Contain CD133+ Cancer Stem Cells Displaying High Tumorigenicity in Vivo. The FASEB Journal, 25, 2022-2030. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Veselska, R., Hermanova, M., Loja, T., Chlapek, P., Zambo, I., Vesely, K., et al. (2008) Nestin Expression in Osteosarcomas and Derivation of Nestin/CD133 Positive Osteosarcoma Cell Lines. BMC Cancer, 8, Article No. 300. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Adhikari, A.S., Agarwal, N., Wood, B.M., Porretta, C., Ruiz, B., Pochampally, R.R., et al. (2010) CD117 and Stro-1 Identify Osteosarcoma Tumor-Initiating Cells Associated with Metastasis and Drug Resistance. Cancer Research, 70, 4602-4612. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Tian, J., Li, X., Si, M., Liu, T. and Li, J. (2014) CD271+ Osteosarcoma Cells Display Stem-Like Properties. PLOS ONE, 9, e98549. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
范兆阳, 尹彩星, 鲜文峰, 等. 利用蛋白组学技术探讨骨肉瘤肺转移患儿血清中蛋白表达情况[J]. 中国卫生检验杂志, 2023, 33(3): 261-265.
|
|
[39]
|
Douville, J., Beaulieu, R. and Balicki, D. (2009) ALDH1 as a Functional Marker of Cancer Stem and Progenitor Cells. Stem Cells and Development, 18, 17-26. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Wang, L., Park, P., Zhang, H., La Marca, F. and Lin, C. (2010) Prospective Identification of Tumorigenic Osteosarcoma Cancer Stem Cells in OS99‐1 Cells Based on High Aldehyde Dehydrogenase Activity. International Journal of Cancer, 128, 294-303. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Fuchs, B. and Pritchard, D.J. (2002) Etiology of Osteosarcoma. Clinical Orthopaedics and Related Research, 397, 40-52. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Hauben, E.I., Arends, J., Vandenbroucke, J.P., van Asperen, C.J., Van Marck, E. and Hogendoorn, P.C.W. (2003) Multiple Primary Malignancies in Osteosarcoma Patients. Incidence and Predictive Value of Osteosarcoma Subtype for Cancer Syndromes Related with Osteosarcoma. European Journal of Human Genetics, 11, 611-618. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Hameetman, L., Bovée, J.V., Taminiau, A.H., Kroon, H.M. and Hogendoorn, P.C. (2004) Multiple Osteochondromas: Clinicopathological and Genetic Spectrum and Suggestions for Clinical Management. Hereditary Cancer in Clinical Practice, 2, 161-173. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Gronchi, A., Miah, A.B., Dei Tos, A.P., Abecassis, N., Bajpai, J., Bauer, S., et al. (2021) Soft Tissue and Visceral Sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. Annals of Oncology, 32, 1348-1365. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Rosenberg, A.E., Nielsen, G.P., Keel, S.B., Renard, L.G., Fitzek, M.M., Munzenrider, J.E., et al. (1999) Chondrosarcoma of the Base of the Skull: A Clinicopathologic Study of 200 Cases with Emphasis on Its Distinction from Chordoma. The American Journal of Surgical Pathology, 23, 1370-1378. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Oktay, K., Aliyev, A., Alcan, H.E., Erdogan, S., Ozsoy, K.M., Cetinalp, N.E., et al. (2023) Extraskeletal Myxoid Chondrosarcoma of the Jugular Foramen in a Pediatric Patient: A Case Report and Comprehensive Review of the Literature. Pediatric Neurosurgery, 58, 173-178. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Lichtenstein, L. and Bernstein, D. (1959) Unusual Benign and Malignant Chondroid Tumors of Bone. A Survey of Some Mesenchymal Cartilage Tumors and Malignant Chondroblastic Tumors, Including a Few Multicentric Ones, as Well as Many Atypical Benign Chondroblastomas and Chondromyxoid Fibromas. Cancer, 12, 1142-1157. [Google Scholar] [CrossRef]
|
|
[48]
|
Theodorou, D.J., Theodorou, S.J., Xenakis, T., et al. (2001) Mesenchymal Chondrosarcoma of Soft Tissues of the Calf. The American Journal of Orthopedics (Belle Mead NJ), 30, 329-332.
|
|
[49]
|
Nguyen, B.D., Daffner, R.H., Dash, N., Rothfus, W.E., Nathan, G. and Toca, A.R. (1993) Case Report 790. Mesenchymal Chondrosarcoma of the Sacrum. Skeletal Radiology, 22, 362-366. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Kruse, R., Simon, R.G., Stanton, R., et al. (1997) Mesenchymal Chondrosarcoma of the Cervical Spine in a Child. The American Journal of Orthopedics (Belle Mead NJ), 26, 279-282.
|
|
[51]
|
Amer, K.M., Munn, M., Congiusta, D., Abraham, J.A. and Basu Mallick, A. (2019) Survival and Prognosis of Chondrosarcoma Subtypes: SEER Database Analysis. Journal of Orthopaedic Research, 38, 311-319. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Amary, M.F., Bacsi, K., Maggiani, F., Damato, S., Halai, D., Berisha, F., et al. (2011) idh1 and idh2 Mutations Are Frequent Events in Central Chondrosarcoma and Central and Periosteal Chondromas but Not in Other Mesenchymal Tumours. The Journal of Pathology, 224, 334-343. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Wang, L., Motoi, T., Khanin, R., Olshen, A., Mertens, F., Bridge, J., et al. (2011) Identification of a Novel, Recurrent HEY1-NCOA2 Fusion in Mesenchymal Chondrosarcoma Based on a Genome‐Wide Screen of Exon‐Level Expression Data. Genes, Chromosomes and Cancer, 51, 127-139. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Smeland, S., Bielack, S.S., Whelan, J., Bernstein, M., Hogendoorn, P., Krailo, M.D., et al. (2019) Survival and Prognosis with Osteosarcoma: Outcomes in More than 2000 Patients in the EURAMOS-1 (European and American Osteosarcoma Study) Cohort. European Journal of Cancer, 109, 36-50. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Bieling, P., Rehan, N., Winkler, P., Helmke, K., Maas, R., Fuchs, N., et al. (1996) Tumor Size and Prognosis in Aggressively Treated Osteosarcoma. Journal of Clinical Oncology, 14, 848-858. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Kaste, S.C., Liu, T., Billups, C.A., Daw, N.C., Pratt, C.B. and Meyer, W.H. (2004) Tumor Size as a Predictor of Outcome in Pediatric Non‐Metastatic Osteosarcoma of the Extremity. Pediatric Blood & Cancer, 43, 723-728. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Bernthal, N.M., Federman, N., Eilber, F.R., Nelson, S.D., Eckardt, J.J., Eilber, F.C., et al. (2012) Long‐Term Results (> 25 Years) of a Randomized, Prospective Clinical Trial Evaluating Chemotherapy in Patients with High‐Grade, Operable Osteosarcoma. Cancer, 118, 5888-5893. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Link, M.P., Goorin, A.M., Miser, A.W., Green, A.A., Pratt, C.B., Belasco, J.B., et al. (1986) The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the Extremity. New England Journal of Medicine, 314, 1600-1606. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Carter, S.K. (1980) The Dilemma of Adjuvant Chemotherapy for Osteogenic Sarcoma. Cancer Clinical Trials, 3, 29-36.
|
|
[60]
|
曹莉莉, 朱岩, 樊根涛, 等. 骨肉瘤的治疗进展[J]. 中国骨与关节杂志, 2020, 9(10): 771-778.
|
|
[61]
|
Anninga, J.K., Gelderblom, H., Fiocco, M., Kroep, J.R., Taminiau, A.H.M., Hogendoorn, P.C.W., et al. (2011) Chemotherapeutic Adjuvant Treatment for Osteosarcoma: Where Do We Stand? European Journal of Cancer, 47, 2431-2445. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Marina, N.M., Smeland, S., Bielack, S.S., Bernstein, M., Jovic, G., Krailo, M.D., et al. (2016) Comparison of MAPIE versus MAP in Patients with a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-Grade Osteosarcoma (EURAMOS-1): An Open-Label, International, Randomised Controlled Trial. The Lancet Oncology, 17, 1396-1408. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Whelan, J.S., Bielack, S.S., Marina, N., Smeland, S., Jovic, G., Hook, J.M., et al. (2015) EURAMOS-1, an International Randomised Study for Osteosarcoma: Results from Pre-Randomisation Treatment. Annals of Oncology, 26, 407-414. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Ferrari, S., Smeland, S., Mercuri, M., Bertoni, F., Longhi, A., Ruggieri, P., et al. (2005) Neoadjuvant Chemotherapy with High-Dose Ifosfamide, High-Dose Methotrexate, Cisplatin, and Doxorubicin for Patients with Localized Osteosarcoma of the Extremity: A Joint Study by the Italian and Scandinavian Sarcoma Groups. Journal of Clinical Oncology, 23, 8845-8852. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Papakonstantinou, E., Stamatopoulos, A., I Athanasiadis, D., Kenanidis, E., Potoupnis, M., Haidich, A., et al. (2020) Limb-Salvage Surgery Offers Better Five-Year Survival Rate than Amputation in Patients with Limb Osteosarcoma Treated with Neoadjuvant Chemotherapy. A Systematic Review and Meta-Analysis. Journal of Bone Oncology, 25, Article ID: 100319. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Kaneuchi, Y., Yoshida, S., Fujiwara, T., Evans, S. and Abudu, A. (2022) Limb Salvage Surgery Has a Higher Complication Rate than Amputation but Is Still Beneficial for Patients Younger than 10 Years Old with Osteosarcoma of an Extremity. Journal of Pediatric Surgery, 57, 702-709. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Zhu, Y., Wu, X., Zhang, W. and Zhang, H. (2023) Limb-Salvage Surgery versus Extremity Amputation for Early-Stage Bone Cancer in the Extremities: A Population-Based Study. Frontiers in Surgery, 10, Article ID: 1147372. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
孙寅, 董扬. 儿童骨肉瘤保骺保肢手术研究进展[J]. 国际骨科学杂志, 2024, 45(3): 153-156.
|
|
[69]
|
牛晓辉. 骨肉瘤治疗的历史、现状和未来[J]. 骨科临床与研究杂志, 2019, 4(5): 257-260.
|
|
[70]
|
Zitvogel, L., Tesniere, A., Apetoh, L., Ghiringhelli, F. and Kroemer, G. (2008) Immunological Aspects of Anticancer Chemotherapy. Bulletin de l’Académie Nationale de Médecine, 192, 1469-1489. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Moore, C., Eslin, D., Levy, A., Roberson, J., Giusti, V. and Sutphin, R. (2010) Prognostic Significance of Early Lymphocyte Recovery in Pediatric Osteosarcoma. Pediatric Blood & Cancer, 55, 1096-1102. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
童晨曦, 宋银宏. 嵌合抗原受体基因修饰的T细胞免疫治疗骨肉瘤的研究进展[J]. 基础医学与临床, 2018, 38(7): 1012-1015.
|
|
[73]
|
吕浩晗, 郑文静, 王延峰, 等. 具有中央记忆T细胞表型的新型CAR-T细胞的制备及其对GD2阳性人骨肉瘤细胞的杀伤作用[J]. 细胞与分子免疫学杂志, 2023, 39(10): 872-877.
|
|
[74]
|
施锦涛, 张凯, 张芮浩, 等. PD-1/PD-L1轴与骨肉瘤治疗研究进展[J]. 解放军医学杂志, 2021, 46(1): 89-94.
|
|
[75]
|
谭芷芬, 张宏方, 郝晓霞, 等. 褪黑素在骨肉瘤治疗中的应用机制[J]. 中国比较医学杂志, 2021, 31(12): 115-120.
|
|
[76]
|
Fromm, J., Klein, A., Baur-Melnyk, A., Knösel, T., Lindner, L., Birkenmaier, C., et al. (2018) Survival and Prognostic Factors in Conventional Central Chondrosarcoma. BMC Cancer, 18, Article No. 849. [Google Scholar] [CrossRef] [PubMed]
|
|
[77]
|
Lee, A.F., Hayes, M.M., LeBrun, D., Espinosa, I., Nielsen, G.P., Rosenberg, A.E., et al. (2011) FLI-1 Distinguishes Ewing Sarcoma from Small Cell Osteosarcoma and Mesenchymal Chondrosarcoma. Applied Immunohistochemistry & Molecular Morphology, 19, 233-238. [Google Scholar] [CrossRef] [PubMed]
|
|
[78]
|
Moussavi-Harami, F., Mollano, A., Martin, J.A., Ayoob, A., Domann, F.E., Gitelis, S., et al. (2006) Intrinsic Radiation Resistance in Human Chondrosarcoma Cells. Biochemical and Biophysical Research Communications, 346, 379-385. [Google Scholar] [CrossRef] [PubMed]
|
|
[79]
|
Arshi, A., Sharim, J., Park, D.Y., Park, H.Y., Bernthal, N.M., Yazdanshenas, H., et al. (2017) Chondrosarcoma of the Osseous Spine: An Analysis of Epidemiology, Patient Outcomes, and Prognostic Factors Using the SEER Registry from 1973 to 2012. Spine, 42, 644-652. [Google Scholar] [CrossRef] [PubMed]
|
|
[80]
|
Harwood, A.R., Ivan, J. and Fornasier, V.L. (1981) Mesenchymal Chondrosarcoma: A Report of 17 Cases. Clinical Orthopaedics and Related Research, 158, 144-148. [Google Scholar] [CrossRef]
|
|
[81]
|
Miao, R., Choy, E., Raskin, K.A., Schwab, J.H., Nielsen, G.P., Deshpande, V., et al. (2019) Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single Institution. Sarcoma, 2019, Article ID: 9069272. [Google Scholar] [CrossRef] [PubMed]
|
|
[82]
|
Staals, E.L., Bacchini, P. and Bertoni, F. (2006) Dedifferentiated Central Chondrosarcoma. Cancer, 106, 2682-2691. [Google Scholar] [CrossRef] [PubMed]
|
|
[83]
|
Strotman, P.K., Reif, T.J., Kliethermes, S.A., Sandhu, J.K. and Nystrom, L.M. (2017) Dedifferentiated Chondrosarcoma: A Survival Analysis of 159 Cases from the SEER Database (2001‐2011). Journal of Surgical Oncology, 116, 252-257. [Google Scholar] [CrossRef] [PubMed]
|
|
[84]
|
Grimer, R.J., Gosheger, G., Taminiau, A., Biau, D., Matejovsky, Z., Kollender, Y., et al. (2007) Dedifferentiated Chondrosarcoma: Prognostic Factors and Outcome from a European Group. European Journal of Cancer, 43, 2060-2065. [Google Scholar] [CrossRef] [PubMed]
|
|
[85]
|
郎锦义. 中国放疗三十年回顾、思考与展望[J]. 肿瘤预防与治疗, 2017, 30(1): 1-4.
|
|
[86]
|
刘玉连, 赵徵鑫, 张文艺, 等. 质子放射治疗的现状与展望[J]. 中国医学装备, 2017, 14(7): 139-143.
|
|
[87]
|
Ioakeim-Ioannidou, M., Goldberg, S., Urell, T., Tejada, A., Nielsen, G.P., Hung, Y.P., et al. (2025) Proton-Based Radiation Therapy for Skull Base Chondrosarcomas in Children and Adolescents: 40-Year Experience from the Massachusetts General Hospital. International Journal of Radiation Oncology Biology Physics, 121, 403-413. [Google Scholar] [CrossRef] [PubMed]
|
|
[88]
|
Mohan, R. and Grosshans, D. (2017) Proton Therapy—Present and Future. Advanced Drug Delivery Reviews, 109, 26-44. [Google Scholar] [CrossRef] [PubMed]
|
|
[89]
|
Schippers, J.M., Lomax, A., Garonna, A. and Parodi, K. (2018) Can Technological Improvements Reduce the Cost of Proton Radiation Therapy? Seminars in Radiation Oncology, 28, 150-159. [Google Scholar] [CrossRef] [PubMed]
|
|
[90]
|
Blay, J., Soibinet, P., Penel, N., Bompas, E., Duffaud, F., Stoeckle, E., et al. (2017) Improved Survival Using Specialized Multidisciplinary Board in Sarcoma Patients. Annals of Oncology, 28, 2852-2859. [Google Scholar] [CrossRef] [PubMed]
|
|
[91]
|
Widhe, B. and Bauer, H.C.F. (2009) Surgical Treatment Is Decisive for Outcome in Chondrosarcoma of the Chest Wall: A Population-Based Scandinavian Sarcoma Group Study of 106 Patients. The Journal of Thoracic and Cardiovascular Surgery, 137, 610-614. [Google Scholar] [CrossRef] [PubMed]
|